ZM336372, A Raf-1 Activator, Inhibits Growth of Pheochromocytoma Cells

Journal of Surgical Research

Volumn 133, Issue 1, 2006, Pages 42-45

  Kappes, Ashley ^a,b   Vaccaro, Abram ^a,b   Kunnimalaiyaan, Muthusamy ^a,b   Chen, Herbert ^a,b  

^a Endocrine Surgery Research Laboratories   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

adrenal; neuroendocrine; paraganglioma; pheochromocytoma; raf 1; signal transduction

Indexed keywords

CHROMOGRANIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N [5 (3 DIMETHYLAMINOBENZAMIDO) 2 METHYLPHENYL] 4 HYDROXYBENZAMIDE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER PATIENT; CELL ASSAY; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; NEUROENDOCRINE TUMOR; NONHUMAN; PALLIATIVE THERAPY; PHEOCHROMOCYTOMA CELL; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; TUMOR CELL; WESTERN BLOTTING;

ANIMALS; BENZAMIDES; CELL PROLIFERATION; CHROMOGRANIN A; CHROMOGRANINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PC12 CELLS; PHEOCHROMOCYTOMA; PROTO-ONCOGENE PROTEINS C-RAF; RATS;

EID: 33646254621     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.02.002     Document Type: Article

References (16)

1. Sheps S.G., Jiang N.S., and Klee G.G. Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am 17 (1988) 397 [Review] [43 refs]
2. Grant C.S. Pheochromocytoma. In: OH C., Q D., and E K. (Eds). Textbook of endocrine surgery (2005), Elsevier Saunders Co, Philadelphia, PA 621-633
3. Chen H., Doppman J.L., Chrousos G.P., et al. Adrenocorticotropic hormone-secreting pheochromocytomas. the exception to the rule. Surgery 118 (1995) 988
4. Younes N., Fulton N., Tanaka R., et al. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79 (1997) 1804
5. Kunnimalaiyaan M., and Chen H. Raf-1 pathway. a molecular target for treatment of select neuroendocrine tumors?. Anticancer Drugs 17 (2006) 139
6. Paraskevakou H., Saetta A., Skandalis K., et al. Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids. Pathol Oncol Res 5 (1999) 205
7. Yashiro T., Fulton N., Hara H., et al. Comparison of mutations of ras oncogene in human pancreatic exocrine and endocrine tumors. Surgery 114 (1993) 758
8. Chen H., Kunnimalaiyaan M., and Van Compel J. Medullary thyroid cancer. the functions of raf-1 and human achaete-scute homolog-1. Thyroid 16 (2005) 515
9. Park J.I., Strock C.J., Ball D.W., et al. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 23 (2003) 543
10. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., et al. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery 134 (2003) 866
11. Sippel R.S., Carpenter J.E., Kunnimalaiyaan M., et al. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 285 (2003) G245
12. Sippel R.S., and Chen H. Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery 132 (2002) 1035
13. Van Gompel J.J., Kunnimalaiyaan M., Holen K., et al. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther 4 (2005) 910
14. Hall-Jackson C.A., Eyers P.A., Cohen P., et al. Paradoxical activation of Raf by a novel Raf inhibitor. Chem Biol 6 (1999) 559
15. Chen H., Carson-Walter E.B., Baylin S.B., et al. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1. Surgery 120 (1996) 168
16. Lal A., and Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol 18 (2006) 9